disease_id,disease_name,gene_id,gene_name,,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:100133941,"CD24, CD24A; CD24 molecule; K06469 CD24 antigen",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:1791,"DNTT, TDT; DNA nucleotidylexotransferase (EC:2.7.7.31); K00977 DNA nucleotidylexotransferase [EC:2.7.7.31]",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:2120,"ETV6, TEL, TEL/ABL; ets variant 6; K03211 ETS translocation variant 6/7",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:25,"ABL1, ABL, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl; ABL proto-oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2); K06619 abelson tyrosine-protein kinase 1 [EC:2.7.10.2]",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:4297,"KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1, MLL1A, TET1-MLL, TRX1, WDSTS; lysine (K)-specific methyltransferase 2A (EC:2.1.1.43); K09186 histone-lysine N-methyltransferase MLL1 [EC:2.1.1.43]",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:4299,"AFF1, AF4, MLLT2, PBM1; AF4/FMR2 family, member 1; K15184 AF4/FMR2 family member 1",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:4311,"MME, CALLA, CD10, NEP, SFE; membrane metallo-endopeptidase (EC:3.4.24.11); K01389 neprilysin [EC:3.4.24.11]",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:5087,PBX1; pre-B-cell leukemia homeobox 1; K09355 pre-B-cell leukemia transcription factor 1,,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:613,"BCR, ALL, BCR1, CML, D22S11, D22S662, PHL; breakpoint cluster region (EC:2.7.11.1); K08878 breakpoint cluster region protein [EC:2.7.11.1]",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:6929,"TCF3, E2A, E47, ITF1, TCF-3, VDIR, bHLHb21; transcription factor 3; K09063 transcription factor E2-alpha",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:7490,"WT1, AWT1, EWS-WT1, GUD, NPHS4, WAGR, WIT-2, WT33; Wilms tumor 1; K09234 Wilms tumor protein 1",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:861,"RUNX1, AML1, AML1-EVI-1, AMLCR1, CBFA2, EVI-1, PEBP2aB; runt-related transcription factor 1; K08367 runt-related transcription factor 1",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:930,"CD19, B4, CVID3; CD19 molecule; K06465 CD19 antigen",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:931,"MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7; membrane-spanning 4-domains, subfamily A, member 1; K06466 membrane-spanning 4-domains, subfamily A, member 1",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:933,"CD22, SIGLEC-2, SIGLEC2; CD22 molecule; K06467 CD22 antigen",,ds:H00001,Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia),hsa:973,"CD79A, IGA, MB-1; CD79a molecule, immunoglobulin-associated alpha; K06506 CD79A antigen",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:1791,"DNTT, TDT; DNA nucleotidylexotransferase (EC:2.7.7.31); K00977 DNA nucleotidylexotransferase [EC:2.7.7.31]",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:30012,"TLX3, HOX11L2, RNX; T-cell leukemia homeobox 3; K15607 T-cell leukemia homeobox protein 3",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:3195,"TLX1, HOX11, TCL3; T-cell leukemia homeobox 1; K09340 T-cell leukemia homeobox protein 1",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:4005,"LMO2, RBTN2, RBTNL1, RHOM2, TTG2; LIM domain only 2 (rhombotin-like 1); K15612 rhombotin-2",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:4066,"LYL1, bHLHa18; lymphoblastic leukemia associated hematopoiesis regulator 1; K15604 protein lyl-1",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:4297,"KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1, MLL1A, TET1-MLL, TRX1, WDSTS; lysine (K)-specific methyltransferase 2A (EC:2.1.1.43); K09186 histone-lysine N-methyltransferase MLL1 [EC:2.1.1.43]",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:4298,"MLLT1, ENL, LTG19, YEATS1; myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1; K15187 YEATS domain-containing protein 1/3",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:4311,"MME, CALLA, CD10, NEP, SFE; membrane metallo-endopeptidase (EC:3.4.24.11); K01389 neprilysin [EC:3.4.24.11]",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:4851,"NOTCH1, TAN1, hN1; notch 1; K02599 Notch",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:6886,"TAL1, SCL, TCL5, bHLHa17, tal-1; T-cell acute lymphocytic leukemia 1; K09068 T-cell acute lymphocytic leukemia protein",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:7490,"WT1, AWT1, EWS-WT1, GUD, NPHS4, WAGR, WIT-2, WT33; Wilms tumor 1; K09234 Wilms tumor protein 1",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:909,"CD1A, CD1, FCB6, HTA1, R4, T6; CD1a molecule; K06448 CD1 antigen",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:914,"CD2, LFA-2, SRBC, T11; CD2 molecule; K06449 CD2 antigen",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:915,"CD3D, CD3-DELTA, IMD19, T3D; CD3d molecule, delta (CD3-TCR complex); K06450 T-cell surface glycoprotein CD3 delta chain",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:916,"CD3E, IMD18, T3E, TCRE; CD3e molecule, epsilon (CD3-TCR complex); K06451 T-cell surface glycoprotein CD3 epsilon chain",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:917,"CD3G, CD3-GAMMA, IMD17, T3G; CD3g molecule, gamma (CD3-TCR complex); K06452 T-cell surface glycoprotein CD3 gamma chain",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:921,"CD5, LEU1, T1; CD5 molecule; K06455 CD5 antigen",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:924,"CD7, GP40, LEU-9, TP41, Tp40; CD7 molecule; K06457 CD7 antigen",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:925,"CD8A, CD8, Leu2, MAL, p32; CD8a molecule; K06458 CD8A antigen, alpha polypeptide",,ds:H00002,Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia),hsa:926,"CD8B, CD8B1, LEU2, LY3, LYT3, P37; CD8b molecule; K06459 CD8B antigen, beta polypeptide",,ds:H00003,Acute myeloid leukemia (AML),hsa:1050,"CEBPA, C/EBP-alpha, CEBP; CCAAT/enhancer binding protein (C/EBP), alpha; K09055 CCAAT/enhancer binding protein (C/EBP), alpha",,ds:H00003,Acute myeloid leukemia (AML),hsa:2209,"FCGR1A, CD64, CD64A, FCRI, IGFR1; Fc fragment of IgG, high affinity Ia, receptor (CD64); K06498 high affinity immunoglobulin gamma Fc receptor I",,ds:H00003,Acute myeloid leukemia (AML),hsa:2322,"FLT3, CD135, FLK-2, FLK2, STK1; fms-related tyrosine kinase 3 (EC:2.7.10.1); K05092 fms-related tyrosine kinase 3 [EC:2.7.10.1]",,ds:H00003,Acute myeloid leukemia (AML),hsa:290,"ANPEP, APN, CD13, GP150, LAP1, P150, PEPN; alanyl (membrane) aminopeptidase (EC:3.4.11.2); K11140 aminopeptidase N [EC:3.4.11.2]",,ds:H00003,Acute myeloid leukemia (AML),hsa:3815,"KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]",,ds:H00003,Acute myeloid leukemia (AML),hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00003,Acute myeloid leukemia (AML),hsa:4353,MPO; myeloperoxidase (EC:1.11.2.2); K10789 myeloperoxidase [EC:1.11.2.2],,ds:H00003,Acute myeloid leukemia (AML),hsa:4629,"MYH11, AAT4, FAA4, SMHC, SMMHC; myosin, heavy chain 11, smooth muscle; K10352 myosin heavy chain",,ds:H00003,Acute myeloid leukemia (AML),hsa:4893,"NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas",,ds:H00003,Acute myeloid leukemia (AML),hsa:5371,"PML, MYL, PP8675, RNF71, TRIM19; promyelocytic leukemia; K10054 probable transcription factor PML",,ds:H00003,Acute myeloid leukemia (AML),hsa:5914,"RARA, NR1B1, RAR; retinoic acid receptor, alpha; K08527 retinoic acid receptor alpha",,ds:H00003,Acute myeloid leukemia (AML),hsa:6688,"SPI1, OF, PU.1, SFPI1, SPI-1, SPI-A; Spi-1 proto-oncogene; K09438 transcription factor PU.1",,ds:H00003,Acute myeloid leukemia (AML),hsa:7490,"WT1, AWT1, EWS-WT1, GUD, NPHS4, WAGR, WIT-2, WT33; Wilms tumor 1; K09234 Wilms tumor protein 1",,ds:H00003,Acute myeloid leukemia (AML),hsa:7704,"ZBTB16, PLZF, ZNF145; zinc finger and BTB domain containing 16; K10055 zinc finger and BTB domain-containing protein 16",,ds:H00003,Acute myeloid leukemia (AML),hsa:861,"RUNX1, AML1, AML1-EVI-1, AMLCR1, CBFA2, EVI-1, PEBP2aB; runt-related transcription factor 1; K08367 runt-related transcription factor 1",,ds:H00003,Acute myeloid leukemia (AML),hsa:862,"RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2; runt-related transcription factor 1; translocated to, 1 (cyclin D-related); K10053 runt-related transcription factor 1; translocated to, 1",,ds:H00003,Acute myeloid leukemia (AML),hsa:865,"CBFB, PEBP2B; core-binding factor, beta subunit",,ds:H00003,Acute myeloid leukemia (AML),hsa:929,CD14; CD14 molecule; K04391 CD14 antigen,,ds:H00003,Acute myeloid leukemia (AML),hsa:945,"CD33, SIGLEC-3, SIGLEC3, p67; CD33 molecule; K06473 CD33 antigen",,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:2208,"FCER2, BLAST-2, CD23, CD23A, CLEC4J, FCE2, IGEBF; Fc fragment of IgE, low affinity II, receptor for (CD23); K06468 Fc receptor, IgE, low affinity II",,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:355,"FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas cell surface death receptor; K04390 tumor necrosis factor receptor superfamily member 6",,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:472,"ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1; ATM serine/threonine kinase (EC:2.7.11.1); K04728 ataxia telangiectasia mutated family protein [EC:2.7.11.1]",,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:567,B2M; beta-2-microglobulin; K08055 beta-2-microglobulin,,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:596,"BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2",,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:7083,"TK1, TK2; thymidine kinase 1, soluble (EC:2.7.1.21); K00857 thymidine kinase [EC:2.7.1.21]",,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:7535,"ZAP70, SRK, STCD, STD, TZK, ZAP-70; zeta-chain (TCR) associated protein kinase 70kDa (EC:2.7.10.2); K07360 tyrosine-protein kinase ZAP-70 [EC:2.7.10.2]",,ds:H00005,Chronic lymphocytic leukemia (CLL),hsa:952,"CD38, ADPRC_1, T10; CD38 molecule (EC:3.2.2.6 2.4.99.20); K01242 ADP-ribosyl cyclase 1 [EC:3.2.2.6 2.4.99.20]",,ds:H00006,Hairy-cell leukemia,hsa:301,"ANXA1, ANX1, LPC1; annexin A1; K17091 annexin A1",,ds:H00006,Hairy-cell leukemia,hsa:3559,"IL2RA, CD25, IDDM10, IL2R, TCGFR, p55; interleukin 2 receptor, alpha; K05068 interleukin 2 receptor alpha",,ds:H00006,Hairy-cell leukemia,hsa:3682,"ITGAE, CD103, HUMINAE; integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide); K06524 integrin alpha E",,ds:H00006,Hairy-cell leukemia,hsa:3687,"ITGAX, CD11C, SLEB6; integrin, alpha X (complement component 3 receptor 4 subunit); K06462 integrin alpha X",,ds:H00006,Hairy-cell leukemia,hsa:595,"CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1",,ds:H00006,Hairy-cell leukemia,hsa:604,"BCL6, BCL5, BCL6A, LAZ3, ZBTB27, ZNF51; B-cell CLL/lymphoma 6; K15618 B-cell lymphoma 6 protein",,ds:H00006,Hairy-cell leukemia,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00007,Hodgkin lymphoma,hsa:355,"FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas cell surface death receptor; K04390 tumor necrosis factor receptor superfamily member 6",,ds:H00007,Hodgkin lymphoma,hsa:3586,"IL10, CSIF, GVHDS, IL-10, IL10A, TGIF; interleukin 10; K05443 interleukin 10",,ds:H00007,Hodgkin lymphoma,hsa:4792,"NFKBIA, IKBA, MAD-3, NFKBI; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; K04734 NF-kappa-B inhibitor alpha",,ds:H00007,Hodgkin lymphoma,hsa:4794,"NFKBIE, IKBE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon; K05872 NF-kappa-B inhibitor epsilon",,ds:H00007,Hodgkin lymphoma,hsa:5966,"REL, C-Rel; v-rel avian reticuloendotheliosis viral oncogene homolog; K09254 c-Rel proto-oncogene protein",,ds:H00007,Hodgkin lymphoma,hsa:943,"TNFRSF8, CD30, D1S166E, Ki-1; tumor necrosis factor receptor superfamily, member 8; K05145 tumor necrosis factor receptor superfamily member 8",,ds:H00008,Burkitt lymphoma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00008,Burkitt lymphoma,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00008,Burkitt lymphoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00009,Adult T-cell leukemia,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00009,Adult T-cell leukemia,hsa:332,"BIRC5, API4, EPR-1; baculoviral IAP repeat containing 5; K08731 baculoviral IAP repeat-containing protein 5",,ds:H00009,Adult T-cell leukemia,hsa:355,"FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas cell surface death receptor; K04390 tumor necrosis factor receptor superfamily member 6",,ds:H00009,Adult T-cell leukemia,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00010,Multiple myeloma,hsa:197257,"LDHD, DLD; lactate dehydrogenase D (EC:1.1.2.4); K00102 D-lactate dehydrogenase (cytochrome) [EC:1.1.2.4]",,ds:H00010,Multiple myeloma,hsa:2261,"FGFR3, ACH, CD333, CEK2, HSFGFR3EX, JTK4; fibroblast growth factor receptor 3 (EC:2.7.10.1); K05094 fibroblast growth factor receptor 3 [EC:2.7.10.1]",,ds:H00010,Multiple myeloma,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00010,Multiple myeloma,hsa:3939,"LDHA, GSD11, HEL-S-133P, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00010,Multiple myeloma,hsa:3945,"LDHB, HEL-S-281, LDH-B, LDH-H, LDHBD, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00010,Multiple myeloma,hsa:3948,"LDHC, CT32, LDH3, LDHX; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00010,Multiple myeloma,hsa:4094,"MAF, CCA4, c-MAF; v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog; K09035 transcription factor Maf",,ds:H00010,Multiple myeloma,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00010,Multiple myeloma,hsa:4684,"NCAM1, CD56, MSK39, NCAM; neural cell adhesion molecule 1 (EC:2.7.11.1); K06491 neural cell adhesion molecule",,ds:H00010,Multiple myeloma,hsa:4685,"NCAM2, NCAM21; neural cell adhesion molecule 2; K06491 neural cell adhesion molecule",,ds:H00010,Multiple myeloma,hsa:4893,"NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas",,ds:H00010,Multiple myeloma,hsa:567,B2M; beta-2-microglobulin; K08055 beta-2-microglobulin,,ds:H00010,Multiple myeloma,hsa:595,"CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1",,ds:H00010,Multiple myeloma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00010,Multiple myeloma,hsa:7468,"WHSC1, MMSET, NSD2, REIIBP, TRX5, WHS; Wolf-Hirschhorn syndrome candidate 1 (EC:2.1.1.43); K11424 histone-lysine N-methyltransferase NSD2 [EC:2.1.1.43]",,ds:H00010,Multiple myeloma,hsa:896,CCND3; cyclin D3; K10152 cyclin D3,,ds:H00011,Lymphoplasmacytic lymphoma,hsa:5079,"PAX5, ALL3, BSAP; paired box 5; K09383 paired box protein 5",,ds:H00011,Lymphoplasmacytic lymphoma,hsa:930,"CD19, B4, CVID3; CD19 molecule; K06465 CD19 antigen",,ds:H00011,Lymphoplasmacytic lymphoma,hsa:931,"MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7; membrane-spanning 4-domains, subfamily A, member 1; K06466 membrane-spanning 4-domains, subfamily A, member 1",,ds:H00012,Polycythemia vera,hsa:2056,"EPO, EP, MVCD2; erythropoietin; K05437 erythropoietin",,ds:H00012,Polycythemia vera,hsa:3717,"JAK2, JTK10, THCYT3; Janus kinase 2 (EC:2.7.10.2); K04447 Janus kinase 2 [EC:2.7.10.2]",,ds:H00012,Polycythemia vera,hsa:57126,"CD177, HNA-2a, HNA2A, NB1, NB1_GP, PRV-1, PRV1; CD177 molecule; K06552 CD177 antigen",,ds:H00013,Small cell lung cancer,hsa:2026,"ENO2, HEL-S-279, NSE; enolase 2 (gamma, neuronal) (EC:4.2.1.11); K01689 enolase [EC:4.2.1.11]",,ds:H00013,Small cell lung cancer,hsa:2272,"FHIT, AP3Aase, FRA3B; fragile histidine triad (EC:3.6.1.29); K01522 bis(5'-adenosyl)-triphosphatase [EC:3.6.1.29]",,ds:H00013,Small cell lung cancer,hsa:2922,"GRP, BN, GRP-10, preproGRP, proGRP; gastrin-releasing peptide; K05224 gastrin-releasing peptide",,ds:H00013,Small cell lung cancer,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00013,Small cell lung cancer,hsa:5728,"PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]",,ds:H00013,Small cell lung cancer,hsa:5915,"RARB, HAP, MCOPS12, NR1B2, RRB2; retinoic acid receptor, beta; K08528 retinoic acid receptor beta",,ds:H00013,Small cell lung cancer,hsa:5925,"RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein",,ds:H00013,Small cell lung cancer,hsa:596,"BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2",,ds:H00013,Small cell lung cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00014,Non-small cell lung cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00014,Non-small cell lung cancer,hsa:10342,"TFG, HMSNP, SPG57, TF6, TRKT3; TRK-fused gene; K09292 protein TFG",,ds:H00014,Non-small cell lung cancer,hsa:1048,"CEACAM5, CD66e, CEA; carcinoembryonic antigen-related cell adhesion molecule 5; K06499 carcinoembryonic antigen-related cell adhesion molecule",,ds:H00014,Non-small cell lung cancer,hsa:10568,"SLC34A2, NAPI-3B, NAPI-IIb, NPTIIb; solute carrier family 34 (type II sodium/phosphate contransporter), member 2; K14683 solute carrier family 34 (sodium-dependent phosphate cotransporter)",,ds:H00014,Non-small cell lung cancer,hsa:11186,"RASSF1, 123F2, NORE2A, RASSF1A, RDA32, REH3P21; Ras association (RalGDS/AF-6) domain family member 1; K09850 Ras association domain-containing protein 1",,ds:H00014,Non-small cell lung cancer,hsa:2272,"FHIT, AP3Aase, FRA3B; fragile histidine triad (EC:3.6.1.29); K01522 bis(5'-adenosyl)-triphosphatase [EC:3.6.1.29]",,ds:H00014,Non-small cell lung cancer,hsa:238,"ALK, CD246, NBLST3; anaplastic lymphoma receptor tyrosine kinase (EC:2.7.10.1); K05119 anaplastic lymphoma kinase [EC:2.7.10.1]",,ds:H00014,Non-small cell lung cancer,hsa:27436,"EML4, C2orf2, ELP120, EMAP-4, EMAPL4, ROPP120; echinoderm microtubule associated protein like 4; K15420 echinoderm microtubule-associated protein-like 4",,ds:H00014,Non-small cell lung cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00014,Non-small cell lung cancer,hsa:3880,"KRT19, CK19, K19, K1CS; keratin 19; K07604 type I keratin, acidic",,ds:H00014,Non-small cell lung cancer,hsa:5915,"RARB, HAP, MCOPS12, NR1B2, RRB2; retinoic acid receptor, beta; K08528 retinoic acid receptor beta",,ds:H00014,Non-small cell lung cancer,hsa:6098,"ROS1, MCF3, ROS, c-ros-1; ROS proto-oncogene 1, receptor tyrosine kinase (EC:2.7.10.1); K05088 proto-oncogene tyrosine-protein kinase ROS [EC:2.7.10.1]",,ds:H00014,Non-small cell lung cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00015,Malignant pleural mesothelioma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00015,Malignant pleural mesothelioma,hsa:1030,"CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); K04685 cyclin-dependent kinase inhibitor 2B",,ds:H00015,Malignant pleural mesothelioma,hsa:286887,"KRT6C, K6E, KRT6E, PPKNEFD; keratin 6C; K07605 type II keratin, basic",,ds:H00015,Malignant pleural mesothelioma,hsa:3479,"IGF1, IGF-I, IGF1A, IGFI; insulin-like growth factor 1 (somatomedin C); K05459 insulin-like growth factor 1",,ds:H00015,Malignant pleural mesothelioma,hsa:3480,"IGF1R, CD221, IGFIR, IGFR, JTK13; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]",,ds:H00015,Malignant pleural mesothelioma,hsa:3852,"KRT5, CK5, DDD, DDD1, EBS2, K5, KRT5A; keratin 5; K07605 type II keratin, basic",,ds:H00015,Malignant pleural mesothelioma,hsa:3853,"KRT6A, CK6A, CK6C, CK6D, K6A, K6C, K6D, KRT6C, KRT6D, PC3; keratin 6A; K07605 type II keratin, basic",,ds:H00015,Malignant pleural mesothelioma,hsa:3854,"KRT6B, CK-6B, CK6B, K6B, KRTL1, PC2, PC4; keratin 6B; K07605 type II keratin, basic",,ds:H00015,Malignant pleural mesothelioma,hsa:4771,"NF2, ACN, BANF, SCH; neurofibromin 2 (merlin); K16684 merlin",,ds:H00015,Malignant pleural mesothelioma,hsa:5154,"PDGFA, PDGF-A, PDGF1; platelet-derived growth factor alpha polypeptide; K04359 platelet-derived growth factor subunit A",,ds:H00015,Malignant pleural mesothelioma,hsa:5155,"PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis; platelet-derived growth factor beta polypeptide; K17386 platelet-derived growth factor subunit B",,ds:H00015,Malignant pleural mesothelioma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00015,Malignant pleural mesothelioma,hsa:7490,"WT1, AWT1, EWS-WT1, GUD, NPHS4, WAGR, WIT-2, WT33; Wilms tumor 1; K09234 Wilms tumor protein 1",,ds:H00015,Malignant pleural mesothelioma,hsa:794,"CALB2, CAB29, CAL2, CR; calbindin 2",,ds:H00016,Oral cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00016,Oral cancer,hsa:1956,"EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]",,ds:H00016,Oral cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00016,Oral cancer,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00016,Oral cancer,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00016,Oral cancer,hsa:4893,"NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas",,ds:H00016,Oral cancer,hsa:5925,"RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein",,ds:H00016,Oral cancer,hsa:595,"CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1",,ds:H00016,Oral cancer,hsa:6774,"STAT3, APRF, HIES; signal transducer and activator of transcription 3 (acute-phase response factor); K04692 signal transducer and activator of transcription 3",,ds:H00016,Oral cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00017,Esophageal cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00017,Esophageal cancer,hsa:1956,"EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]",,ds:H00017,Esophageal cancer,hsa:324,"APC, BTPS2, DP2, DP2.5, DP3, GS, PPP1R46; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein",,ds:H00017,Esophageal cancer,hsa:355,"FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6; Fas cell surface death receptor; K04390 tumor necrosis factor receptor superfamily member 6",,ds:H00017,Esophageal cancer,hsa:4843,"NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]",,ds:H00017,Esophageal cancer,hsa:5743,"PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]",,ds:H00017,Esophageal cancer,hsa:5925,"RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein",,ds:H00017,Esophageal cancer,hsa:595,"CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1",,ds:H00017,Esophageal cancer,hsa:7039,"TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha",,ds:H00017,Esophageal cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00018,Gastric cancer,hsa:1048,"CEACAM5, CD66e, CEA; carcinoembryonic antigen-related cell adhesion molecule 5; K06499 carcinoembryonic antigen-related cell adhesion molecule",,ds:H00018,Gastric cancer,hsa:1499,"CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1",,ds:H00018,Gastric cancer,hsa:1630,"DCC, CRC18, CRCR1, IGDCC1, MRMV1, NTN1R1; DCC netrin 1 receptor; K06765 deleted in colorectal carcinoma",,ds:H00018,Gastric cancer,hsa:1950,"EGF, HOMG4, URG; epidermal growth factor; K04357 epidermal growth factor",,ds:H00018,Gastric cancer,hsa:1956,"EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]",,ds:H00018,Gastric cancer,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00018,Gastric cancer,hsa:2263,"FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1]",,ds:H00018,Gastric cancer,hsa:2277,"FIGF, VEGF-D, VEGFD; c-fos induced growth factor (vascular endothelial growth factor D); K05449 vascular endothelial growth factor C/D",,ds:H00018,Gastric cancer,hsa:324,"APC, BTPS2, DP2, DP2.5, DP3, GS, PPP1R46; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein",,ds:H00018,Gastric cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00018,Gastric cancer,hsa:4233,"MET, AUTS9, HGFR, RCCP2, c-Met; MET proto-oncogene, receptor tyrosine kinase (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]",,ds:H00018,Gastric cancer,hsa:596,"BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2",,ds:H00018,Gastric cancer,hsa:7039,"TGFA, TFGA; transforming growth factor, alpha; K08774 transforming growth factor, alpha",,ds:H00018,Gastric cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00018,Gastric cancer,hsa:7422,"VEGFA, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A",,ds:H00018,Gastric cancer,hsa:7423,"VEGFB, VEGFL, VRF; vascular endothelial growth factor B; K16858 vascular endothelial growth factor B",,ds:H00018,Gastric cancer,hsa:7424,"VEGFC, Flt4-L, LMPH1D, VRP; vascular endothelial growth factor C; K05449 vascular endothelial growth factor C/D",,ds:H00018,Gastric cancer,hsa:898,"CCNE1, CCNE; cyclin E1; K06626 cyclin E",,ds:H00018,Gastric cancer,hsa:9134,"CCNE2, CYCE2; cyclin E2; K06626 cyclin E",,ds:H00018,Gastric cancer,hsa:960,"CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen",,ds:H00018,Gastric cancer,hsa:999,"CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin",,ds:H00019,Pancreatic cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00019,Pancreatic cancer,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00019,Pancreatic cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00019,Pancreatic cancer,hsa:4089,"SMAD4, DPC4, JIP, MADH4, MYHRS; SMAD family member 4; K04501 mothers against decapentaplegic homolog 4",,ds:H00019,Pancreatic cancer,hsa:6696,"SPP1, BNSP, BSPI, ETA-1, OPN; secreted phosphoprotein 1; K06250 secreted phosphoprotein 1",,ds:H00019,Pancreatic cancer,hsa:675,"BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD, FANCD1, GLM3, PNCA2; breast cancer 2, early onset; K08775 breast cancer 2 susceptibility protein",,ds:H00019,Pancreatic cancer,hsa:6794,"STK11, LKB1, PJS, hLKB1; serine/threonine kinase 11 (EC:2.7.11.1); K07298 serine/threonine-protein kinase 11",,ds:H00019,Pancreatic cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00019,Pancreatic cancer,hsa:9518,"GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB; growth differentiation factor 15; K05504 growth differentiation factor 15",,ds:H00020,Colorectal cancer,hsa:10297,"APC2, APCL; adenomatosis polyposis coli 2; K02085 adenomatosis polyposis coli protein",,ds:H00020,Colorectal cancer,hsa:1499,"CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1",,ds:H00020,Colorectal cancer,hsa:1630,"DCC, CRC18, CRCR1, IGDCC1, MRMV1, NTN1R1; DCC netrin 1 receptor; K06765 deleted in colorectal carcinoma",,ds:H00020,Colorectal cancer,hsa:2956,"MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160; mutS homolog 6; K08737 DNA mismatch repair protein MSH6",,ds:H00020,Colorectal cancer,hsa:3039,"HBA1, HBA-T3, HBH; hemoglobin, alpha 1; K13822 hemoglobin subunit alpha",,ds:H00020,Colorectal cancer,hsa:3040,"HBA2, HBA-T2, HBH; hemoglobin, alpha 2; K13822 hemoglobin subunit alpha",,ds:H00020,Colorectal cancer,hsa:3043,"HBB, CD113t-C, beta-globin; hemoglobin, beta; K13823 hemoglobin subunit beta",,ds:H00020,Colorectal cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00020,Colorectal cancer,hsa:4087,"SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2; SMAD family member 2; K04500 mothers against decapentaplegic homolog 2/3",,ds:H00020,Colorectal cancer,hsa:4089,"SMAD4, DPC4, JIP, MADH4, MYHRS; SMAD family member 4; K04501 mothers against decapentaplegic homolog 4",,ds:H00020,Colorectal cancer,hsa:4292,"MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1; mutL homolog 1; K08734 DNA mismatch repair protein MLH1",,ds:H00020,Colorectal cancer,hsa:4436,"MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2; mutS homolog 2; K08735 DNA mismatch repair protein MSH2",,ds:H00020,Colorectal cancer,hsa:4437,"MSH3, DUP, MRP1; mutS homolog 3; K08736 DNA mismatch repair protein MSH3",,ds:H00020,Colorectal cancer,hsa:581,"BAX, BCL2L4; BCL2-associated X protein; K02159 apoptosis regulator BAX",,ds:H00020,Colorectal cancer,hsa:7048,"TGFBR2, AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2, RIIC, TAAD2, TGFR-2, TGFbeta-RII; transforming growth factor, beta receptor II (70/80kDa) (EC:2.7.11.30); K04388 TGF-beta receptor type-2 [EC:2.7.11.30]",,ds:H00020,Colorectal cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00021,Renal cell carcinoma,hsa:201163,"FLCN, BHD, FLCL; folliculin; K09594 folliculin",,ds:H00021,Renal cell carcinoma,hsa:2271,"FH, HLRCC, LRCC, MCL, MCUL1; fumarate hydratase (EC:4.2.1.2); K01679 fumarate hydratase, class II [EC:4.2.1.2]",,ds:H00021,Renal cell carcinoma,hsa:2277,"FIGF, VEGF-D, VEGFD; c-fos induced growth factor (vascular endothelial growth factor D); K05449 vascular endothelial growth factor C/D",,ds:H00021,Renal cell carcinoma,hsa:2934,"GSN, ADF, AGEL; gelsolin; K05768 gelsolin",,ds:H00021,Renal cell carcinoma,hsa:4233,"MET, AUTS9, HGFR, RCCP2, c-Met; MET proto-oncogene, receptor tyrosine kinase (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]",,ds:H00021,Renal cell carcinoma,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00021,Renal cell carcinoma,hsa:5546,"PRCC, RCCP1, TPRC; papillary renal cell carcinoma (translocation-associated); K13105 proline-rich protein PRCC",,ds:H00021,Renal cell carcinoma,hsa:7030,"TFE3, RCCP2, RCCX1, TFEA, bHLHe33; transcription factor binding to IGHM enhancer 3; K09105 transcription factor E3",,ds:H00021,Renal cell carcinoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00021,Renal cell carcinoma,hsa:7422,"VEGFA, MVCD1, VEGF, VPF; vascular endothelial growth factor A; K05448 vascular endothelial growth factor A",,ds:H00021,Renal cell carcinoma,hsa:7423,"VEGFB, VEGFL, VRF; vascular endothelial growth factor B; K16858 vascular endothelial growth factor B",,ds:H00021,Renal cell carcinoma,hsa:7424,"VEGFC, Flt4-L, LMPH1D, VRP; vascular endothelial growth factor C; K05449 vascular endothelial growth factor C/D",,ds:H00021,Renal cell carcinoma,hsa:7428,"VHL, HRCA1, RCA1, VHL1, pVHL; von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase; K03871 von Hippel-Lindau disease tumor supressor",,ds:H00021,Renal cell carcinoma,hsa:7431,"VIM, CTRCT30, HEL113; vimentin; K07606 vimentin",,ds:H00021,Renal cell carcinoma,hsa:768,"CA9, CAIX, MN; carbonic anhydrase IX (EC:4.2.1.1); K01672 carbonic anhydrase [EC:4.2.1.1]",,ds:H00021,Renal cell carcinoma,hsa:771,"CA12, CAXII, HsT18816; carbonic anhydrase XII (EC:4.2.1.1); K01672 carbonic anhydrase [EC:4.2.1.1]",,ds:H00021,Renal cell carcinoma,hsa:960,"CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen",,ds:H00022,Bladder cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00022,Bladder cancer,hsa:1048,"CEACAM5, CD66e, CEA; carcinoembryonic antigen-related cell adhesion molecule 5; K06499 carcinoembryonic antigen-related cell adhesion molecule",,ds:H00022,Bladder cancer,hsa:10724,"MGEA5, MEA5, NCOAT, OGA; meningioma expressed antigen 5 (hyaluronidase) (EC:2.3.1.48 3.2.1.169); K15719 protein O-GlcNAcase / histone acetyltransferase [EC:3.2.1.169 2.3.1.48]",,ds:H00022,Bladder cancer,hsa:10877,"CFHR4, CFHL4, FHR-4, FHR4; complement factor H-related 4",,ds:H00022,Bladder cancer,hsa:10878,"CFHR3, CFHL3, DOWN16, FHR-3, FHR3, HLF4; complement factor H-related 3",,ds:H00022,Bladder cancer,hsa:11186,"RASSF1, 123F2, NORE2A, RASSF1A, RDA32, REH3P21; Ras association (RalGDS/AF-6) domain family member 1; K09850 Ras association domain-containing protein 1",,ds:H00022,Bladder cancer,hsa:1612,"DAPK1, DAPK; death-associated protein kinase 1 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1]",,ds:H00022,Bladder cancer,hsa:1956,"EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]",,ds:H00022,Bladder cancer,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00022,Bladder cancer,hsa:2261,"FGFR3, ACH, CD333, CEK2, HSFGFR3EX, JTK4; fibroblast growth factor receptor 3 (EC:2.7.10.1); K05094 fibroblast growth factor receptor 3 [EC:2.7.10.1]",,ds:H00022,Bladder cancer,hsa:3039,"HBA1, HBA-T3, HBH; hemoglobin, alpha 1; K13822 hemoglobin subunit alpha",,ds:H00022,Bladder cancer,hsa:3040,"HBA2, HBA-T2, HBH; hemoglobin, alpha 2; K13822 hemoglobin subunit alpha",,ds:H00022,Bladder cancer,hsa:3043,"HBB, CD113t-C, beta-globin; hemoglobin, beta; K13823 hemoglobin subunit beta",,ds:H00022,Bladder cancer,hsa:3075,"CFH, AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH, FHL1, HF, HF1, HF2, HUS; complement factor H (EC:4.2.1.2); K04004 complement factor H",,ds:H00022,Bladder cancer,hsa:3078,"CFHR1, CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2; complement factor H-related 1",,ds:H00022,Bladder cancer,hsa:3080,"CFHR2, CFHL2, FHR2, HFL3; complement factor H-related 2",,ds:H00022,Bladder cancer,hsa:3265,"HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas",,ds:H00022,Bladder cancer,hsa:332,"BIRC5, API4, EPR-1; baculoviral IAP repeat containing 5; K08731 baculoviral IAP repeat-containing protein 5",,ds:H00022,Bladder cancer,hsa:3856,"KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO; keratin 8; K07605 type II keratin, basic",,ds:H00022,Bladder cancer,hsa:3875,"KRT18, CYK18, K18; keratin 18; K07604 type I keratin, acidic",,ds:H00022,Bladder cancer,hsa:3880,"KRT19, CK19, K19, K1CS; keratin 19; K07604 type I keratin, acidic",,ds:H00022,Bladder cancer,hsa:4926,"NUMA1, NUMA; nuclear mitotic apparatus protein 1; K16808 nuclear mitotic apparatus protein 1",,ds:H00022,Bladder cancer,hsa:54474,"KRT20, CD20, CK-20, CK20, K20, KRT21; keratin 20; K07604 type I keratin, acidic",,ds:H00022,Bladder cancer,hsa:5925,"RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein",,ds:H00022,Bladder cancer,hsa:7015,"TERT, CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT; telomerase reverse transcriptase (EC:2.7.7.49); K11126 telomerase reverse transcriptase [EC:2.7.7.49]",,ds:H00022,Bladder cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00022,Bladder cancer,hsa:81494,"CFHR5, CFHL5, CFHR5D, FHR-5, FHR5; complement factor H-related 5",,ds:H00023,Testicular cancer,hsa:1082,"CGB, CGB3, CGB5, CGB7, CGB8, hCGB; chorionic gonadotropin, beta polypeptide; K10045 chorionic gonadotropin, beta polypeptide",,ds:H00023,Testicular cancer,hsa:174,"AFP, FETA, HPAFP; alpha-fetoprotein; K16144 alpha-fetoprotein",,ds:H00023,Testicular cancer,hsa:197257,"LDHD, DLD; lactate dehydrogenase D (EC:1.1.2.4); K00102 D-lactate dehydrogenase (cytochrome) [EC:1.1.2.4]",,ds:H00023,Testicular cancer,hsa:251,"ALPPL2, ALPG, ALPPL, GCAP; alkaline phosphatase, placental-like 2 (EC:3.1.3.1); K01077 alkaline phosphatase [EC:3.1.3.1]",,ds:H00023,Testicular cancer,hsa:3815,"KIT, C-Kit, CD117, PBT, SCFR; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1); K05091 proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]",,ds:H00023,Testicular cancer,hsa:3939,"LDHA, GSD11, HEL-S-133P, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00023,Testicular cancer,hsa:3945,"LDHB, HEL-S-281, LDH-B, LDH-H, LDHBD, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00023,Testicular cancer,hsa:3948,"LDHC, CT32, LDH3, LDHX; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00023,Testicular cancer,hsa:5460,"POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4; POU class 5 homeobox 1; K09367 POU domain transcription factor, class 5",,ds:H00023,Testicular cancer,hsa:894,"CCND2, KIAK0002, MPPH3; cyclin D2; K10151 cyclin D2",,ds:H00024,Prostate cancer,hsa:1027,"CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B",,ds:H00024,Prostate cancer,hsa:1655,"DDX5, G17P1, HLR1, HUMP68, p68; DEAD (Asp-Glu-Ala-Asp) box helicase 5 (EC:3.6.4.13); K12823 ATP-dependent RNA helicase DDX5/DBP2 [EC:3.6.4.13]",,ds:H00024,Prostate cancer,hsa:2005,"ELK4, SAP1; ELK4, ETS-domain protein (SRF accessory protein 1); K04376 ETS domain-containing protein Elk-4",,ds:H00024,Prostate cancer,hsa:2078,"ERG, erg-3, p55; v-ets avian erythroblastosis virus E26 oncogene homolog; K09435 transcriptional regulator ERG",,ds:H00024,Prostate cancer,hsa:2115,"ETV1, ER81; ets variant 1; K09431 ets translocation variant 1",,ds:H00024,Prostate cancer,hsa:2118,"ETV4, E1A-F, E1AF, PEA3, PEAS3; ets variant 4; K15592 ets translocation variant 4",,ds:H00024,Prostate cancer,hsa:2119,"ETV5, ERM; ets variant 5; K15593 ets translocation variant 5",,ds:H00024,Prostate cancer,hsa:23600,"AMACR, AMACRD, CBAS4, RACE, RM; alpha-methylacyl-CoA racemase (EC:5.1.99.4); K01796 alpha-methylacyl-CoA racemase [EC:5.1.99.4]",,ds:H00024,Prostate cancer,hsa:2950,"GSTP1, DFN7, FAEES3, GST3, GSTP, HEL-S-22, PI; glutathione S-transferase pi 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]",,ds:H00024,Prostate cancer,hsa:354,"KLK3, APS, KLK2A1, PSA, hK3; kallikrein-related peptidase 3 (EC:3.4.21.77); K01351 semenogelase [EC:3.4.21.77]",,ds:H00024,Prostate cancer,hsa:367,"AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM; androgen receptor; K08557 androgen receptor",,ds:H00024,Prostate cancer,hsa:4824,"NKX3-1, BAPX2, NKX3, NKX3.1, NKX3A; NK3 homeobox 1; K09348 homeobox protein Nkx-3.1",,ds:H00024,Prostate cancer,hsa:5728,"PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]",,ds:H00024,Prostate cancer,hsa:7015,"TERT, CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT; telomerase reverse transcriptase (EC:2.7.7.49); K11126 telomerase reverse transcriptase [EC:2.7.7.49]",,ds:H00024,Prostate cancer,hsa:7113,"TMPRSS2, PP9284, PRSS10; transmembrane protease, serine 2 (EC:3.4.21.-); K09633 transmembrane protease, serine 2",,ds:H00024,Prostate cancer,hsa:85414,"SLC45A3, IPCA-2, IPCA-6, IPCA-8, IPCA6, PCANAP2, PCANAP6, PCANAP8, PRST; solute carrier family 45, member 3; K15379 solute carrier family 45, member 3",,ds:H00025,Penile cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00025,Penile cancer,hsa:3265,"HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas",,ds:H00025,Penile cancer,hsa:4193,"MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]",,ds:H00025,Penile cancer,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00025,Penile cancer,hsa:4313,"MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]",,ds:H00025,Penile cancer,hsa:4318,"MMP9, CLG4B, GELB, MANDP2, MMP-9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35); K01403 matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]",,ds:H00025,Penile cancer,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00025,Penile cancer,hsa:5743,"PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]",,ds:H00025,Penile cancer,hsa:648,"BMI1, FLVI2/BMI1, PCGF4, RNF51; BMI1 proto-oncogene, polycomb ring finger; K11459 polycomb group RING finger protein 4",,ds:H00025,Penile cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00025,Penile cancer,hsa:80142,"PTGES2, C9orf15, GBF-1, GBF1, PGES2, mPGES-2; prostaglandin E synthase 2 (EC:5.3.99.3); K05309 microsomal prostaglandin-E synthase 2 [EC:5.3.99.3]",,ds:H00025,Penile cancer,hsa:999,"CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin",,ds:H00026,Endometrial Cancer,hsa:1048,"CEACAM5, CD66e, CEA; carcinoembryonic antigen-related cell adhesion molecule 5; K06499 carcinoembryonic antigen-related cell adhesion molecule",,ds:H00026,Endometrial Cancer,hsa:1499,"CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1",,ds:H00026,Endometrial Cancer,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00026,Endometrial Cancer,hsa:2099,"ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1; estrogen receptor 1; K08550 estrogen receptor alpha",,ds:H00026,Endometrial Cancer,hsa:2100,"ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2; estrogen receptor 2 (ER beta); K08551 estrogen receptor beta",,ds:H00026,Endometrial Cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00026,Endometrial Cancer,hsa:4292,"MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1; mutL homolog 1; K08734 DNA mismatch repair protein MLH1",,ds:H00026,Endometrial Cancer,hsa:5241,"PGR, NR3C3, PR; progesterone receptor; K08556 progesterone receptor",,ds:H00026,Endometrial Cancer,hsa:5728,"PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]",,ds:H00026,Endometrial Cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00026,Endometrial Cancer,hsa:94025,"MUC16, CA125; mucin 16, cell surface associated; K16145 mucin-16",,ds:H00027,Ovarian cancer,hsa:1435,"CSF1, CSF-1, MCSF; colony stimulating factor 1 (macrophage) (EC:2.7.10.1); K05453 macrophage colony-stimulating factor 1",,ds:H00027,Ovarian cancer,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00027,Ovarian cancer,hsa:208,"AKT2, HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA; v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1); K04456 RAC serine/threonine-protein kinase [EC:2.7.11.1]",,ds:H00027,Ovarian cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00027,Ovarian cancer,hsa:4292,"MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1; mutL homolog 1; K08734 DNA mismatch repair protein MLH1",,ds:H00027,Ovarian cancer,hsa:4436,"MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2; mutS homolog 2; K08735 DNA mismatch repair protein MSH2",,ds:H00027,Ovarian cancer,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00027,Ovarian cancer,hsa:5290,"PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]",,ds:H00027,Ovarian cancer,hsa:672,"BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53; breast cancer 1, early onset; K10605 breast cancer type 1 susceptibility protein",,ds:H00027,Ovarian cancer,hsa:675,"BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD, FANCD1, GLM3, PNCA2; breast cancer 2, early onset; K08775 breast cancer 2 susceptibility protein",,ds:H00027,Ovarian cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00027,Ovarian cancer,hsa:94025,"MUC16, CA125; mucin 16, cell surface associated; K16145 mucin-16",,ds:H00028,Choriocarcinoma,hsa:1082,"CGB, CGB3, CGB5, CGB7, CGB8, hCGB; chorionic gonadotropin, beta polypeptide; K10045 chorionic gonadotropin, beta polypeptide",,ds:H00028,Choriocarcinoma,hsa:1436,"CSF1R, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R; colony stimulating factor 1 receptor (EC:2.7.10.1); K05090 macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]",,ds:H00028,Choriocarcinoma,hsa:1956,"EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]",,ds:H00028,Choriocarcinoma,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00028,Choriocarcinoma,hsa:4193,"MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]",,ds:H00028,Choriocarcinoma,hsa:4312,"MMP1, CLG, CLGN; matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7); K01388 matrix metalloproteinase-1 (interstitial collagenase) [EC:3.4.24.7]",,ds:H00028,Choriocarcinoma,hsa:4313,"MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24); K01398 matrix metalloproteinase-2 (gelatinase A) [EC:3.4.24.24]",,ds:H00028,Choriocarcinoma,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00028,Choriocarcinoma,hsa:596,"BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2",,ds:H00028,Choriocarcinoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00029,Vulvar cancer,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00029,Vulvar cancer,hsa:5728,"PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]",,ds:H00029,Vulvar cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00030,Cervical cancer,hsa:1019,"CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]",,ds:H00030,Cervical cancer,hsa:1026,"CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A",,ds:H00030,Cervical cancer,hsa:1956,"EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]",,ds:H00030,Cervical cancer,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00030,Cervical cancer,hsa:3265,"HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas",,ds:H00030,Cervical cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00030,Cervical cancer,hsa:3880,"KRT19, CK19, K19, K1CS; keratin 19; K07604 type I keratin, acidic",,ds:H00030,Cervical cancer,hsa:596,"BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2",,ds:H00030,Cervical cancer,hsa:6317,"SERPINB3, HsT1196, SCC, SCCA-1, SCCA-PD, SCCA1, T4-A; serpin peptidase inhibitor, clade B (ovalbumin), member 3; K13963 serpin B",,ds:H00031,Breast cancer,hsa:1048,"CEACAM5, CD66e, CEA; carcinoembryonic antigen-related cell adhesion molecule 5; K06499 carcinoembryonic antigen-related cell adhesion molecule",,ds:H00031,Breast cancer,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00031,Breast cancer,hsa:3856,"KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO; keratin 8; K07605 type II keratin, basic",,ds:H00031,Breast cancer,hsa:3875,"KRT18, CYK18, K18; keratin 18; K07604 type I keratin, acidic",,ds:H00031,Breast cancer,hsa:3880,"KRT19, CK19, K19, K1CS; keratin 19; K07604 type I keratin, acidic",,ds:H00031,Breast cancer,hsa:4582,"MUC1, ADMCKD, ADMCKD1, CA_15-3, CD227, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM; mucin 1, cell surface associated; K06568 mucin 1, transmembrane",,ds:H00031,Breast cancer,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00031,Breast cancer,hsa:5728,"PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]",,ds:H00031,Breast cancer,hsa:5925,"RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein",,ds:H00031,Breast cancer,hsa:595,"CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1",,ds:H00031,Breast cancer,hsa:672,"BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53; breast cancer 1, early onset; K10605 breast cancer type 1 susceptibility protein",,ds:H00031,Breast cancer,hsa:675,"BRCA2, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD, FANCD1, GLM3, PNCA2; breast cancer 2, early onset; K08775 breast cancer 2 susceptibility protein",,ds:H00031,Breast cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00031,Breast cancer,hsa:999,"CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin",,ds:H00032,Thyroid cancer,hsa:10342,"TFG, HMSNP, SPG57, TF6, TRKT3; TRK-fused gene; K09292 protein TFG",,ds:H00032,Thyroid cancer,hsa:1499,"CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1",,ds:H00032,Thyroid cancer,hsa:1803,"DPP4, ADABP, ADCP2, CD26, DPPIV, TP103; dipeptidyl-peptidase 4 (EC:3.4.14.5); K01278 dipeptidyl-peptidase 4 [EC:3.4.14.5]",,ds:H00032,Thyroid cancer,hsa:3265,"HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas",,ds:H00032,Thyroid cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00032,Thyroid cancer,hsa:3880,"KRT19, CK19, K19, K1CS; keratin 19; K07604 type I keratin, acidic",,ds:H00032,Thyroid cancer,hsa:3958,"LGALS3, CBP35, GAL3, GALBP, GALIG, L31, LGALS2, MAC2; lectin, galactoside-binding, soluble, 3; K06831 galectin-3",,ds:H00032,Thyroid cancer,hsa:4893,"NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas",,ds:H00032,Thyroid cancer,hsa:4914,"NTRK1, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]",,ds:H00032,Thyroid cancer,hsa:5468,"PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma; peroxisome proliferator-activated receptor gamma; K08530 peroxisome proliferator-activated receptor gamma",,ds:H00032,Thyroid cancer,hsa:5979,"RET, CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET-ELE1, RET51; ret proto-oncogene (EC:2.7.10.1); K05126 proto-oncogene tyrosine-protein kinase Ret [EC:2.7.10.1]",,ds:H00032,Thyroid cancer,hsa:673,"BRAF, B-RAF1, BRAF1, NS7, RAFB1; B-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]",,ds:H00032,Thyroid cancer,hsa:7038,"TG, AITD3, TGN; thyroglobulin; K10809 thyroglobulin",,ds:H00032,Thyroid cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00032,Thyroid cancer,hsa:7170,"TPM3, CAPM1, CFTD, HEL-189, HEL-S-82p, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TM5, TPMsk3, TRK, hscp30; tropomyosin 3; K09290 tropomyosin 3",,ds:H00032,Thyroid cancer,hsa:7173,"TPO, MSA, TDH2A, TPX; thyroid peroxidase (EC:1.11.1.8); K00431 thyroid peroxidase [EC:1.11.1.8]",,ds:H00032,Thyroid cancer,hsa:7175,"TPR; translocated promoter region, nuclear basket protein; K09291 nucleoprotein TPR",,ds:H00032,Thyroid cancer,hsa:7849,PAX8; paired box 8; K09293 paired box protein 8,,ds:H00032,Thyroid cancer,hsa:8030,"CCDC6, D10S170, H4, PTC, TPC, TST1; coiled-coil domain containing 6; K09288 coiled-coil domain-containing protein 6",,ds:H00032,Thyroid cancer,hsa:8031,"NCOA4, ARA70, ELE1, PTC3, RFG; nuclear receptor coactivator 4; K09289 nuclear receptor coactivator 4",,ds:H00032,Thyroid cancer,hsa:999,"CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin",,ds:H00033,Adrenal carcinoma,hsa:1026,"CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1; cyclin-dependent kinase inhibitor 1A (p21, Cip1); K06625 cyclin-dependent kinase inhibitor 1A",,ds:H00033,Adrenal carcinoma,hsa:1027,"CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B",,ds:H00033,Adrenal carcinoma,hsa:1028,"CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2; cyclin-dependent kinase inhibitor 1C (p57, Kip2); K09993 cyclin-dependent kinase inhibitor 1C",,ds:H00033,Adrenal carcinoma,hsa:2771,"GNAI2, GIP, GNAI2B, H_LUCA15.1, H_LUCA16.1; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2; K04630 guanine nucleotide-binding protein G(i) subunit alpha",,ds:H00033,Adrenal carcinoma,hsa:3481,"IGF2, C11orf43, IGF-II, PP9974; insulin-like growth factor 2 (somatomedin A); K13769 insulin-like growth factor 2",,ds:H00033,Adrenal carcinoma,hsa:4158,"MC2R, ACTHR; melanocortin 2 receptor (adrenocorticotropic hormone); K04200 melanocortin 2 receptor",,ds:H00033,Adrenal carcinoma,hsa:4221,"MEN1, MEAI, SCG2; multiple endocrine neoplasia I; K14970 menin",,ds:H00033,Adrenal carcinoma,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00033,Adrenal carcinoma,hsa:4893,"NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas",,ds:H00033,Adrenal carcinoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00034,Carcinoid,hsa:1113,"CHGA, CGA; chromogranin A (parathyroid secretory protein 1)",,ds:H00034,Carcinoid,hsa:4221,"MEN1, MEAI, SCG2; multiple endocrine neoplasia I; K14970 menin",,ds:H00034,Carcinoid,hsa:6392,"SDHD, CBT1, CII-4, CWS3, PGL, PGL1, QPs3, SDH4, cybS; succinate dehydrogenase complex, subunit D, integral membrane protein; K00237 succinate dehydrogenase (ubiquinone) membrane anchor subunit",,ds:H00035,Ewing's sarcoma,hsa:197257,"LDHD, DLD; lactate dehydrogenase D (EC:1.1.2.4); K00102 D-lactate dehydrogenase (cytochrome) [EC:1.1.2.4]",,ds:H00035,Ewing's sarcoma,hsa:2078,"ERG, erg-3, p55; v-ets avian erythroblastosis virus E26 oncogene homolog; K09435 transcriptional regulator ERG",,ds:H00035,Ewing's sarcoma,hsa:2115,"ETV1, ER81; ets variant 1; K09431 ets translocation variant 1",,ds:H00035,Ewing's sarcoma,hsa:2118,"ETV4, E1A-F, E1AF, PEA3, PEAS3; ets variant 4; K15592 ets translocation variant 4",,ds:H00035,Ewing's sarcoma,hsa:2130,"EWSR1, EWS, bK984G1.4; EWS RNA-binding protein 1; K13209 RNA-binding protein EWS",,ds:H00035,Ewing's sarcoma,hsa:2313,"FLI1, EWSR2, SIC-1; Fli-1 proto-oncogene, ETS transcription factor; K09436 friend leukemia integration 1 transcription factor",,ds:H00035,Ewing's sarcoma,hsa:27087,"B3GAT1, CD57, GLCATP, GLCUATP, HNK1, LEU7, NK-1, NK1; beta-1,3-glucuronyltransferase 1 (EC:2.4.1.135); K00735 galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 [EC:2.4.1.135]",,ds:H00035,Ewing's sarcoma,hsa:3939,"LDHA, GSD11, HEL-S-133P, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00035,Ewing's sarcoma,hsa:3945,"LDHB, HEL-S-281, LDH-B, LDH-H, LDHBD, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00035,Ewing's sarcoma,hsa:3948,"LDHC, CT32, LDH3, LDHX; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00035,Ewing's sarcoma,hsa:4267,"CD99, HBA71, MIC2, MIC2X, MIC2Y, MSK5X; CD99 molecule; K06520 CD99 antigen",,ds:H00035,Ewing's sarcoma,hsa:54738,"FEV, HSRNAFEV, PET-1; FEV (ETS oncogene family); K09437 ETS oncogene family protein FEV",,ds:H00035,Ewing's sarcoma,hsa:6271,"S100A1, S100, S100-alpha, S100A; S100 calcium binding protein A1",,ds:H00035,Ewing's sarcoma,hsa:7431,"VIM, CTRCT30, HEL113; vimentin; K07606 vimentin",,ds:H00036,Osteosarcoma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00036,Osteosarcoma,hsa:1030,"CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); K04685 cyclin-dependent kinase inhibitor 2B",,ds:H00036,Osteosarcoma,hsa:1576,"CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1; cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157); K17689 cytochrome P450, family 3, subfamily A, polypeptide 4 [EC:1.14.13.32 1.14.13.67 1.14.13.97 1.14.13.157 1.14.13.-]",,ds:H00036,Osteosarcoma,hsa:1577,"CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3; cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1); K17690 cytochrome P450, family 3, subfamily A, polypeptide 5 [EC:1.14.14.1]",,ds:H00036,Osteosarcoma,hsa:332,"BIRC5, API4, EPR-1; baculoviral IAP repeat containing 5; K08731 baculoviral IAP repeat-containing protein 5",,ds:H00036,Osteosarcoma,hsa:4193,"MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]",,ds:H00036,Osteosarcoma,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00036,Osteosarcoma,hsa:59,"ACTA2, AAT6, ACTSA, MYMY5; actin, alpha 2, smooth muscle, aorta; K12313 actin, aortic smooth muscle",,ds:H00036,Osteosarcoma,hsa:5925,"RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein",,ds:H00036,Osteosarcoma,hsa:6302,"TSPAN31, SAS; tetraspanin 31; K17356 tetraspanin-13/31",,ds:H00036,Osteosarcoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00036,Osteosarcoma,hsa:7430,"EZR, CVIL, CVL, HEL-S-105, VIL2; ezrin; K08007 villin 2 (ezrin)",,ds:H00037,Alveolar rhabdomyosarcoma,hsa:2308,"FOXO1, FKH1, FKHR, FOXO1A; forkhead box O1; K07201 forkhead box protein O1",,ds:H00037,Alveolar rhabdomyosarcoma,hsa:4193,"MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]",,ds:H00037,Alveolar rhabdomyosarcoma,hsa:4654,"MYOD1, MYF3, MYOD, PUM, bHLHc1; myogenic differentiation 1; K09064 myogenic factor 3",,ds:H00037,Alveolar rhabdomyosarcoma,hsa:4656,"MYOG, MYF4, bHLHc3, myf-4; myogenin (myogenic factor 4); K18483 myogenic factor 4 (myogenin)",,ds:H00037,Alveolar rhabdomyosarcoma,hsa:5077,"PAX3, CDHS, HUP2, WS1, WS3; paired box 3; K09381 paired box protein 3/7",,ds:H00037,Alveolar rhabdomyosarcoma,hsa:5081,"PAX7, HUP1, PAX7B, RMS2; paired box 7; K09381 paired box protein 3/7",,ds:H00037,Alveolar rhabdomyosarcoma,hsa:545,"ATR, FCTCS, FRP1, MEC1, SCKL, SCKL1; ATR serine/threonine kinase (EC:2.7.11.1); K06640 serine/threonine-protein kinase ATR [EC:2.7.11.1]",,ds:H00038,Malignant melanoma,hsa:1019,"CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]",,ds:H00038,Malignant melanoma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00038,Malignant melanoma,hsa:1638,"DCT, TRP-2, TYRP2; dopachrome tautomerase (EC:5.3.3.12); K01827 dopachrome tautomerase [EC:5.3.3.12]",,ds:H00038,Malignant melanoma,hsa:2315,"MLANA, MART-1, MART1; melan-A; K17303 melanoma antigen recognized by T-cells 1",,ds:H00038,Malignant melanoma,hsa:4286,"MITF, CMM8, MI, WS2, WS2A, bHLHe32; microphthalmia-associated transcription factor; K09455 microphthalmia-associated transcription factor",,ds:H00038,Malignant melanoma,hsa:4893,"NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas",,ds:H00038,Malignant melanoma,hsa:5728,"PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]",,ds:H00038,Malignant melanoma,hsa:6271,"S100A1, S100, S100-alpha, S100A; S100 calcium binding protein A1",,ds:H00038,Malignant melanoma,hsa:673,"BRAF, B-RAF1, BRAF1, NS7, RAFB1; B-Raf proto-oncogene, serine/threonine kinase (EC:2.7.11.1); K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]",,ds:H00038,Malignant melanoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00038,Malignant melanoma,hsa:7299,"TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3; tyrosinase (EC:1.14.18.1); K00505 tyrosinase [EC:1.14.18.1]",,ds:H00038,Malignant melanoma,hsa:7306,"TYRP1, CAS2, CATB, GP75, OCA3, TRP, TRP1, TYRP, b-PROTEIN; tyrosinase-related protein 1 (EC:1.14.18.-); K00506 tyrosinase-related protein 1 [EC:1.14.18.-]",,ds:H00038,Malignant melanoma,hsa:7431,"VIM, CTRCT30, HEL113; vimentin; K07606 vimentin",,ds:H00039,Basal cell carcinoma,hsa:5727,"PTCH1, BCNS, HPE7, NBCCS, PTC, PTC1, PTCH, PTCH11; patched 1; K06225 patched 1",,ds:H00039,Basal cell carcinoma,hsa:6469,"SHH, HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS; sonic hedgehog; K11988 sonic hedgehog",,ds:H00039,Basal cell carcinoma,hsa:6608,"SMO, FZD11, Gx, SMOH; smoothened, frizzled class receptor; K06226 smoothened",,ds:H00039,Basal cell carcinoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00039,Basal cell carcinoma,hsa:8626,"TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L; tumor protein p63; K10149 tumor protein p63",,ds:H00040,Squamous cell carcinoma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00040,Squamous cell carcinoma,hsa:3265,"HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas",,ds:H00040,Squamous cell carcinoma,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00040,Squamous cell carcinoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00040,Squamous cell carcinoma,hsa:8626,"TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L; tumor protein p63; K10149 tumor protein p63",,ds:H00041,Kaposi's sarcoma,hsa:2248,"FGF3, HBGF-3, INT2; fibroblast growth factor 3; K04358 fibroblast growth factor",,ds:H00041,Kaposi's sarcoma,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00041,Kaposi's sarcoma,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00041,Kaposi's sarcoma,hsa:596,"BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2",,ds:H00041,Kaposi's sarcoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00042,Glioma,hsa:1019,"CDK4, CMM3, PSK-J3; cyclin-dependent kinase 4 (EC:2.7.11.22); K02089 cyclin-dependent kinase 4 [EC:2.7.11.22]",,ds:H00042,Glioma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00042,Glioma,hsa:1956,"EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]",,ds:H00042,Glioma,hsa:4193,"MDM2, ACTFS, HDMX, hdm2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; K06643 E3 ubiquitin-protein ligase Mdm2 [EC:6.3.2.19]",,ds:H00042,Glioma,hsa:5154,"PDGFA, PDGF-A, PDGF1; platelet-derived growth factor alpha polypeptide; K04359 platelet-derived growth factor subunit A",,ds:H00042,Glioma,hsa:5155,"PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis; platelet-derived growth factor beta polypeptide; K17386 platelet-derived growth factor subunit B",,ds:H00042,Glioma,hsa:5156,"PDGFRA, CD140A, PDGFR-2, PDGFR2, RHEPDGFRA; platelet-derived growth factor receptor, alpha polypeptide (EC:2.7.10.1); K04363 platelet-derived growth factor receptor alpha [EC:2.7.10.1]",,ds:H00042,Glioma,hsa:5159,"PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1; platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1); K05089 platelet-derived growth factor receptor beta [EC:2.7.10.1]",,ds:H00042,Glioma,hsa:5728,"PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]",,ds:H00042,Glioma,hsa:5925,"RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein",,ds:H00042,Glioma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00043,Neuroblastoma,hsa:197257,"LDHD, DLD; lactate dehydrogenase D (EC:1.1.2.4); K00102 D-lactate dehydrogenase (cytochrome) [EC:1.1.2.4]",,ds:H00043,Neuroblastoma,hsa:2026,"ENO2, HEL-S-279, NSE; enolase 2 (gamma, neuronal) (EC:4.2.1.11); K01689 enolase [EC:4.2.1.11]",,ds:H00043,Neuroblastoma,hsa:2495,"FTH1, FHC, FTH, FTHL6, HFE5, PIG15, PLIF; ferritin, heavy polypeptide 1 (EC:1.16.3.1); K00522 ferritin heavy chain [EC:1.16.3.2]",,ds:H00043,Neuroblastoma,hsa:2512,"FTL, LFTD, NBIA3; ferritin, light polypeptide; K13625 ferritin light chain",,ds:H00043,Neuroblastoma,hsa:3939,"LDHA, GSD11, HEL-S-133P, LDH1, LDHM; lactate dehydrogenase A (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00043,Neuroblastoma,hsa:3945,"LDHB, HEL-S-281, LDH-B, LDH-H, LDHBD, TRG-5; lactate dehydrogenase B (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00043,Neuroblastoma,hsa:3948,"LDHC, CT32, LDH3, LDHX; lactate dehydrogenase C (EC:1.1.1.27); K00016 L-lactate dehydrogenase [EC:1.1.1.27]",,ds:H00043,Neuroblastoma,hsa:4613,"MYCN, MODED, N-myc, NMYC, ODED, bHLHe37; v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog; K09109 N-myc proto-oncogene protein",,ds:H00043,Neuroblastoma,hsa:4914,"NTRK1, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]",,ds:H00043,Neuroblastoma,hsa:4915,"NTRK2, GP145-TrkB, TRKB, trk-B; neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1); K04360 neurotrophic tyrosine kinase receptor type 2 [EC:2.7.10.1]",,ds:H00043,Neuroblastoma,hsa:4916,"NTRK3, TRKC, gp145(trkC); neurotrophic tyrosine kinase, receptor, type 3 (EC:2.7.10.1); K05101 neurotrophic tyrosine kinase, receptor type 3 [EC:2.7.10.1]",,ds:H00043,Neuroblastoma,hsa:960,"CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen",,ds:H00044,Cancer of the anal canal,hsa:1630,"DCC, CRC18, CRCR1, IGDCC1, MRMV1, NTN1R1; DCC netrin 1 receptor; K06765 deleted in colorectal carcinoma",,ds:H00044,Cancer of the anal canal,hsa:324,"APC, BTPS2, DP2, DP2.5, DP3, GS, PPP1R46; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein",,ds:H00044,Cancer of the anal canal,hsa:3856,"KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO; keratin 8; K07605 type II keratin, basic",,ds:H00044,Cancer of the anal canal,hsa:3875,"KRT18, CYK18, K18; keratin 18; K07604 type I keratin, acidic",,ds:H00044,Cancer of the anal canal,hsa:3880,"KRT19, CK19, K19, K1CS; keratin 19; K07604 type I keratin, acidic",,ds:H00044,Cancer of the anal canal,hsa:6317,"SERPINB3, HsT1196, SCC, SCCA-1, SCCA-PD, SCCA1, T4-A; serpin peptidase inhibitor, clade B (ovalbumin), member 3; K13963 serpin B",,ds:H00044,Cancer of the anal canal,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00044,Cancer of the anal canal,hsa:8626,"TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L; tumor protein p63; K10149 tumor protein p63",,ds:H00045,Malignant islet cell carcinoma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00045,Malignant islet cell carcinoma,hsa:3880,"KRT19, CK19, K19, K1CS; keratin 19; K07604 type I keratin, acidic",,ds:H00045,Malignant islet cell carcinoma,hsa:4221,"MEN1, MEAI, SCG2; multiple endocrine neoplasia I; K14970 menin",,ds:H00045,Malignant islet cell carcinoma,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00046,Cholangiocarcinoma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00046,Cholangiocarcinoma,hsa:1048,"CEACAM5, CD66e, CEA; carcinoembryonic antigen-related cell adhesion molecule 5; K06499 carcinoembryonic antigen-related cell adhesion molecule",,ds:H00046,Cholangiocarcinoma,hsa:2064,"ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1); K05083 receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]",,ds:H00046,Cholangiocarcinoma,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00046,Cholangiocarcinoma,hsa:4233,"MET, AUTS9, HGFR, RCCP2, c-Met; MET proto-oncogene, receptor tyrosine kinase (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]",,ds:H00046,Cholangiocarcinoma,hsa:5743,"PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]",,ds:H00046,Cholangiocarcinoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00047,Gallbladder cancer,hsa:1027,"CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1; cyclin-dependent kinase inhibitor 1B (p27, Kip1); K06624 cyclin-dependent kinase inhibitor 1B",,ds:H00047,Gallbladder cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00047,Gallbladder cancer,hsa:324,"APC, BTPS2, DP2, DP2.5, DP3, GS, PPP1R46; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein",,ds:H00047,Gallbladder cancer,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00047,Gallbladder cancer,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00047,Gallbladder cancer,hsa:595,"CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1",,ds:H00047,Gallbladder cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00048,Hepatocellular carcinoma,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00048,Hepatocellular carcinoma,hsa:1499,"CTNNB1, CTNNB, MRD19, armadillo; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin beta 1",,ds:H00048,Hepatocellular carcinoma,hsa:174,"AFP, FETA, HPAFP; alpha-fetoprotein; K16144 alpha-fetoprotein",,ds:H00048,Hepatocellular carcinoma,hsa:2678,"GGT1, CD224, D22S672, D22S732, GGT, GGT_1, GTG; gamma-glutamyltransferase 1 (EC:2.3.2.2 3.4.19.13 3.4.19.14); K18592 gamma-glutamyltranspeptidase / glutathione hydrolase / leukotriene-C4 hydrolase [EC:2.3.2.2 3.4.19.13 3.4.19.14]",,ds:H00048,Hepatocellular carcinoma,hsa:2719,"GPC3, DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1; glypican 3; K08109 glypican 3 (OCI-5)",,ds:H00048,Hepatocellular carcinoma,hsa:3265,"HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras; Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas",,ds:H00048,Hepatocellular carcinoma,hsa:3482,"IGF2R, CD222, CIMPR, M6P-R, MPR1, MPRI; insulin-like growth factor 2 receptor; K06564 insulin-like growth factor 2 receptor",,ds:H00048,Hepatocellular carcinoma,hsa:3845,"KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2; Kirsten rat sarcoma viral oncogene homolog; K07827 GTPase KRas",,ds:H00048,Hepatocellular carcinoma,hsa:4893,"NRAS, ALPS4, CMNS, N-ras, NCMS, NRAS1, NS6; neuroblastoma RAS viral (v-ras) oncogene homolog; K07828 GTPase NRas",,ds:H00048,Hepatocellular carcinoma,hsa:5728,"PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67]",,ds:H00048,Hepatocellular carcinoma,hsa:5925,"RB1, OSRC, PPP1R130, RB, p105-Rb, pRb, pp110; retinoblastoma 1; K06618 retinoblastoma-associated protein",,ds:H00048,Hepatocellular carcinoma,hsa:7040,"TGFB1, CED, DPD1, LAP, TGFB, TGFbeta; transforming growth factor, beta 1; K13375 transforming growth factor beta-1",,ds:H00048,Hepatocellular carcinoma,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00048,Hepatocellular carcinoma,hsa:7161,"TP73, P73; tumor protein p73; K10148 tumor protein p73",,ds:H00048,Hepatocellular carcinoma,hsa:8312,"AXIN1, AXIN, PPP1R49; axin 1; K02157 axin 1",,ds:H00048,Hepatocellular carcinoma,hsa:999,"CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin",,ds:H00049,Myxoid liposarcoma,hsa:1649,"DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153; DNA-damage-inducible transcript 3; K04452 DNA damage-inducible transcript 3",,ds:H00049,Myxoid liposarcoma,hsa:2130,"EWSR1, EWS, bK984G1.4; EWS RNA-binding protein 1; K13209 RNA-binding protein EWS",,ds:H00049,Myxoid liposarcoma,hsa:2521,"FUS, ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS; FUS RNA binding protein; K13098 RNA-binding protein FUS",,ds:H00049,Myxoid liposarcoma,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00049,Myxoid liposarcoma,hsa:6271,"S100A1, S100, S100-alpha, S100A; S100 calcium binding protein A1",,ds:H00049,Myxoid liposarcoma,hsa:7431,"VIM, CTRCT30, HEL113; vimentin; K07606 vimentin",,ds:H00050,Synovial sarcoma,hsa:3480,"IGF1R, CD221, IGFIR, IGFR, JTK13; insulin-like growth factor 1 receptor (EC:2.7.10.1); K05087 insulin-like growth factor 1 receptor [EC:2.7.10.1]",,ds:H00050,Synovial sarcoma,hsa:4288,"MKI67, KIA, MIB-, MIB-1, PPP1R105; marker of proliferation Ki-67; K17582 antigen KI-67",,ds:H00050,Synovial sarcoma,hsa:6756,"SSX1, CT5.1, SSRC; synovial sarcoma, X breakpoint 1; K15624 protein SSX1",,ds:H00050,Synovial sarcoma,hsa:6757,"SSX2, CT5.2, CT5.2A, HD21, HOM-MEL-40, SSX; synovial sarcoma, X breakpoint 2; K15625 protein SSX2",,ds:H00050,Synovial sarcoma,hsa:6760,"SS18, SSXT, SYT; synovial sarcoma translocation, chromosome 18; K15623 protein SSXT",,ds:H00051,Alveolar soft part sarcoma,hsa:7030,"TFE3, RCCP2, RCCX1, TFEA, bHLHe33; transcription factor binding to IGHM enhancer 3; K09105 transcription factor E3",,ds:H00051,Alveolar soft part sarcoma,hsa:79058,"ASPSCR1, ASPCR1, ASPL, ASPS, RCC17, TUG, UBXD9, UBXN9; alveolar soft part sarcoma chromosome region, candidate 1; K15627 tether containing UBX domain for GLUT4",,ds:H00052,Clear cell sarcoma of soft tissue,hsa:2130,"EWSR1, EWS, bK984G1.4; EWS RNA-binding protein 1; K13209 RNA-binding protein EWS",,ds:H00052,Clear cell sarcoma of soft tissue,hsa:2315,"MLANA, MART-1, MART1; melan-A; K17303 melanoma antigen recognized by T-cells 1",,ds:H00052,Clear cell sarcoma of soft tissue,hsa:466,"ATF1, EWS-ATF1, FUS/ATF-1, TREB36; activating transcription factor 1; K09053 activating transcription factor 1",,ds:H00052,Clear cell sarcoma of soft tissue,hsa:6271,"S100A1, S100, S100-alpha, S100A; S100 calcium binding protein A1",,ds:H00053,Extraskeletal myxoid chondrosarcoma,hsa:2130,"EWSR1, EWS, bK984G1.4; EWS RNA-binding protein 1; K13209 RNA-binding protein EWS",,ds:H00053,Extraskeletal myxoid chondrosarcoma,hsa:6271,"S100A1, S100, S100-alpha, S100A; S100 calcium binding protein A1",,ds:H00053,Extraskeletal myxoid chondrosarcoma,hsa:6855,"SYP, MRX96, MRXSYP; synaptophysin",,ds:H00053,Extraskeletal myxoid chondrosarcoma,hsa:7431,"VIM, CTRCT30, HEL113; vimentin; K07606 vimentin",,ds:H00053,Extraskeletal myxoid chondrosarcoma,hsa:8013,"NR4A3, CHN, CSMF, MINOR, NOR1, TEC; nuclear receptor subfamily 4, group A, member 3; K08559 nuclear receptor subfamily 4 group A member 3",,ds:H00053,Extraskeletal myxoid chondrosarcoma,hsa:8148,"TAF15, Npl3, RBP56, TAF2N, TAFII68; TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa; K14651 transcription initiation factor TFIID subunit 15",,ds:H00054,Nasopharyngeal cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00054,Nasopharyngeal cancer,hsa:11186,"RASSF1, 123F2, NORE2A, RASSF1A, RDA32, REH3P21; Ras association (RalGDS/AF-6) domain family member 1; K09850 Ras association domain-containing protein 1",,ds:H00054,Nasopharyngeal cancer,hsa:1910,"EDNRB, ABCDS, ET-B, ET-BR, ETB, ETBR, ETRB, HSCR, HSCR2, WS4A; endothelin receptor type B; K04198 endothelin receptor type B",,ds:H00054,Nasopharyngeal cancer,hsa:23705,"CADM1, BL2, IGSF4, IGSF4A, NECL2, Necl-2, RA175, ST17, SYNCAM, TSLC1, sTSLC-1, sgIGSF, synCAM1; cell adhesion molecule 1; K06781 cell adhesion molecule 1",,ds:H00054,Nasopharyngeal cancer,hsa:596,"BCL2, Bcl-2, PPP1R50; B-cell CLL/lymphoma 2; K02161 apoptosis regulator BCL-2",,ds:H00054,Nasopharyngeal cancer,hsa:999,"CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO; cadherin 1, type 1, E-cadherin (epithelial); K05689 cadherin 1, type 1, E-cadherin",,ds:H00055,Laryngeal cancer,hsa:1029,"CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16; cyclin-dependent kinase inhibitor 2A; K06621 cyclin-dependent kinase inhibitor 2A",,ds:H00055,Laryngeal cancer,hsa:1956,"EGFR, ERBB, ERBB1, HER1, PIG61, mENA; epidermal growth factor receptor (EC:2.7.10.1); K04361 epidermal growth factor receptor [EC:2.7.10.1]",,ds:H00055,Laryngeal cancer,hsa:4609,"MYC, MRTL, MYCC, bHLHe39, c-Myc; v-myc avian myelocytomatosis viral oncogene homolog; K04377 Myc proto-oncogene protein",,ds:H00055,Laryngeal cancer,hsa:595,"CCND1, BCL1, D11S287E, PRAD1, U21B31; cyclin D1; K04503 cyclin D1",,ds:H00055,Laryngeal cancer,hsa:7157,"TP53, BCC7, LFS1, P53, TRP53; tumor protein p53; K04451 tumor protein p53",,ds:H00055,Laryngeal cancer,hsa:898,"CCNE1, CCNE; cyclin E1; K06626 cyclin E",,ds:H00055,Laryngeal cancer,hsa:9134,"CCNE2, CYCE2; cyclin E2; K06626 cyclin E",,